[SSY3] 特別シンポジウム3（YECジョイント企画）
Global pharma が見据える将来戦略

[SSY3-1] The way for future scientific innovation; a joint road for global pharma and academia

^○Henri Nico Doods (Research Beyond Borders, Boehringer Ingelheim)

Henri Doods received his PhD in Pharmacology at the University of Amsterdam. He joined Boehringer Ingelheim in 1987 and covered different positions within cardiovascular, pain, obesity , central nervous system and respiratory research. Currently, he heads the Global Department Research Beyond Borders with the responsibility to capture emerging science/new indications and novel technologies/modalities. He is (co) author of more than 135 publications and was involved in progressing > 15 compounds into development.